Log In
BCIQ
Print this Print this
 

NESS1-13/38-47

  Manage Alerts
Collapse Summary General Information
Company Neuroscienze PharmaNess s.c.a r.l.
Description 
Molecular Target Dopamine D2 receptor
Mechanism of ActionDopamine D2 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today